Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Baylor Genetics | RCV003466452 | SCV004206256 | uncertain significance | Adrenocortical carcinoma, hereditary | 2023-07-11 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003779128 | SCV004633233 | uncertain significance | Li-Fraumeni syndrome | 2023-04-16 | criteria provided, single submitter | clinical testing | This sequence change replaces serine, which is neutral and polar, with proline, which is neutral and non-polar, at codon 149 of the TP53 protein (p.Ser149Pro). This variant is not present in population databases (gnomAD no frequency). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies have shown that this missense change does not substantially affect TP53 function (PMID: 12826609, 29979965, 30224644). Advanced modeling performed at Invitae incorporating data from internal and/or published experimental studies (PMID: 12826609, 29979965, 30224644) did not meet the statistical confidence thresholds required to predict the impact of this variant on TP53 function. This variant has not been reported in the literature in individuals affected with TP53-related conditions. |